140 related articles for article (PubMed ID: 8961625)
21. BTK, the tyrosine kinase affected in X-linked agammaglobulinemia.
Vihinen M; Mattsson PT; Smith CI
Front Biosci; 1997 Jan; 2():d27-42. PubMed ID: 9159207
[TBL] [Abstract][Full Text] [Related]
22. A new point mutation involving a highly conserved leucine in the Btk SH2 domain in a family with X linked agammaglobulinaemia.
Ohashi Y; Tsuchiya S; Konno T
J Med Genet; 1995 Jan; 32(1):77-8. PubMed ID: 7897635
[No Abstract] [Full Text] [Related]
23. Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: a nationwide study of Btk deficiency in Greece.
Speletas M; Kanariou M; Kanakoudi-Tsakalidou F; Papadopoulou-Alataki E; Arvanitidis K; Pardali E; Constantopoulos A; Kartalis G; Vihinen M; Sideras P; Ritis K
Scand J Immunol; 2001 Sep; 54(3):321-7. PubMed ID: 11555397
[TBL] [Abstract][Full Text] [Related]
24. Mutation analysis in Bruton's tyrosine kinase, the X-linked agammaglobulinaemia gene, including identification of an insertional hotspot.
Gaspar HB; Bradley LA; Katz F; Lovering RC; Roifman CM; Morgan G; Levinsky RJ; Kinnon C
Hum Mol Genet; 1995 Apr; 4(4):755-7. PubMed ID: 7633429
[No Abstract] [Full Text] [Related]
25. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes.
Thomas JD; Sideras P; Smith CI; Vorechovský I; Chapman V; Paul WE
Science; 1993 Jul; 261(5119):355-8. PubMed ID: 8332900
[TBL] [Abstract][Full Text] [Related]
26. Point mutation in intron 11 of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia.
Shinomiya N; Kanegane H; Watanabe A; Yamaguchi Y; Futatani T; Miyawaki T
Pediatr Int; 2000 Dec; 42(6):689-92. PubMed ID: 11192530
[No Abstract] [Full Text] [Related]
27. Kinase mutant Btk results in atypical X-linked agammaglobulinaemia phenotype.
Gaspar HB; Ferrando M; Caragol I; Hernandez M; Bertran JM; De Gracia X; Lester T; Kinnon C; Ashton E; Espanol T
Clin Exp Immunol; 2000 May; 120(2):346-50. PubMed ID: 10792386
[TBL] [Abstract][Full Text] [Related]
28. X linked agammaglobulinaemia with a 'leaky' phenotype.
Jones A; Bradley L; Alterman L; Tarlow M; Thompson R; Kinnon C; Morgan G
Arch Dis Child; 1996 Jun; 74(6):548-9. PubMed ID: 8758136
[TBL] [Abstract][Full Text] [Related]
29. Neutropenia in X-linked agammaglobulinemia.
Farrar JE; Rohrer J; Conley ME
Clin Immunol Immunopathol; 1996 Dec; 81(3):271-6. PubMed ID: 8938104
[TBL] [Abstract][Full Text] [Related]
30. DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia.
Vorechovský I; Vihinen M; de Saint Basile G; Honsová S; Hammarström L; Müller S; Nilsson L; Fischer A; Smith CI
Hum Mol Genet; 1995 Jan; 4(1):51-8. PubMed ID: 7711734
[TBL] [Abstract][Full Text] [Related]
31. X-chromosome inactivation and mutation pattern in the Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Italian XLA Collaborative Group.
Moschese V; Orlandi P; Plebani A; Arvanitidis K; Fiorini M; Speletas M; Mella P; Ritis K; Sideras P; Finocchi A; Livadiotti S; Rossi P
Mol Med; 2000 Feb; 6(2):104-13. PubMed ID: 10859027
[TBL] [Abstract][Full Text] [Related]
32. The spectrum of mutations in Btk that cause X-linked agammaglobulinemia.
Conley ME; Rohrer J
Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 2):S192-7. PubMed ID: 7554467
[No Abstract] [Full Text] [Related]
33. Hypogammaglobulinemia: fifty years later.
Conley ME
Clin Immunol; 2002 Sep; 104(3):201-3. PubMed ID: 12217328
[No Abstract] [Full Text] [Related]
34. Detection of Bruton's tyrosine kinase mutations in hypogammaglobulinaemic males registered as common variable immunodeficiency (CVID) in the Japanese Immunodeficiency Registry.
Kanegane H; Tsukada S; Iwata T; Futatani T; Nomura K; Yamamoto J; Yoshida T; Agematsu K; Komiyama A; Miyawaki T
Clin Exp Immunol; 2000 Jun; 120(3):512-7. PubMed ID: 10844531
[TBL] [Abstract][Full Text] [Related]
35. X-linked agammaglobulinemia and other immunoglobulin deficiencies.
Smith CI; Islam KB; Vorechovský I; Olerup O; Wallin E; Rabbani H; Baskin B; Hammarström L
Immunol Rev; 1994 Apr; 138():159-83. PubMed ID: 8070814
[No Abstract] [Full Text] [Related]
36. Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton's tyrosine kinase: phosphotyrosine-binding and circular dichroism analysis.
Mattsson PT; Lappalainen I; Bäckesjö CM; Brockmann E; Laurén S; Vihinen M; Smith CI
J Immunol; 2000 Apr; 164(8):4170-7. PubMed ID: 10754312
[TBL] [Abstract][Full Text] [Related]
37. Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase.
Conley ME; Fitch-Hilgenberg ME; Cleveland JL; Parolini O; Rohrer J
Hum Mol Genet; 1994 Oct; 3(10):1751-6. PubMed ID: 7849697
[TBL] [Abstract][Full Text] [Related]
38. Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia.
Hagemann TL; Chen Y; Rosen FS; Kwan SP
Hum Mol Genet; 1994 Oct; 3(10):1743-9. PubMed ID: 7880320
[TBL] [Abstract][Full Text] [Related]
39. Missense mutations affecting a conserved cysteine pair in the TH domain of Btk.
Vihinen M; Nore BF; Mattsson PT; Bäckesjö CM; Nars M; Koutaniemi S; Watanabe C; Lester T; Jones A; Ochs HD; Smith CI
FEBS Lett; 1997 Aug; 413(2):205-10. PubMed ID: 9280283
[TBL] [Abstract][Full Text] [Related]
40. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases.
Vetrie D; Vorechovský I; Sideras P; Holland J; Davies A; Flinter F; Hammarström L; Kinnon C; Levinsky R; Bobrow M
Nature; 1993 Jan; 361(6409):226-33. PubMed ID: 8380905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
